Pedro Cavaleiro Miranda

Pedro Cavaleiro Miranda

Auto-generated profile, based on publicly available information

Pedro Cavaleiro Miranda

Universidade de Lisboa

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Clinical Neurophysiology
Verified
Journal Article
Open access
AWA.J. Woods
A.J. Woods
AAA. Antal
A. Antal
MBM. Bikson
M. Bikson
PBP.S. Boggio
P.S. Boggio
ABAndre R. Brunoni
Andre R. Brunoni
MNM.A. Nitsche
M.A. Nitsche
Transcranial electrical stimulation (tES), including transcranial direct and alternating current stimulation (tDCS, tACS) are non-invasive brain stimulation techniques increasingly used for modulation of central nervous system excitability in humans. Here we address methodological issues required for tES application. This review covers technical aspects of tES, as well as applications like exploration of brain physiology, modelling approaches, tES in cognitive neurosciences, and interventional approaches. It aims to help the reader to appropriately design and conduct studies involving these brain stimulation techniques, understand limitations and avoid shortcomings, which might hamper the scientific rigor and potential applications in the clinical domain.

1 September 2017 in Clinical Neurophysiology
Verified
Journal Article
Open access
AAAndrea Antal
Andrea Antal
IAI. Alekseichuk
I. Alekseichuk
MBM. Bikson
M. Bikson
JBJ. Brockmöller
J. Brockmöller
ABAndre R. Brunoni
Andre R. Brunoni
WPW. Paulus
W. Paulus
Low intensity transcranial electrical stimulation (TES) in humans, encompassing transcranial direct current (tDCS), transcutaneous spinal Direct Current Stimulation (tsDCS), transcranial alternating current (tACS), and transcranial random noise (tRNS) stimulation or their combinations, appears to be safe. No serious adverse events (SAEs) have been reported so far in over 18,000 sessions administered to healthy subjects, neurological and psychiatric patients, as summarized here. Moderate adverse events (AEs), as defined by the necessity to intervene, are rare, and include skin burns with tDCS due to suboptimal electrode-skin contact. Very rarely mania or hypomania was induced in patients with depression (11 documented cases), yet a causal relationship is difficult to prove because of the low incidence rate and limited numbers of subjects in controlled trials. Mild AEs (MAEs) include headache and fatigue following stimulation as well as prickling and burning sensations occurring during tDCS at peak-to-baseline intensities of 1-2mA and during tACS at higher peak-to-peak intensities above 2mA. The prevalence of published AEs is different in studies specifically assessing AEs vs. those not assessing them, being higher in the former. AEs are frequently reported by individuals receiving placebo stimulation. The profile of AEs in terms of frequency, magnitude and type is comparable in healthy and clinical populations, and this is also the case for more vulnerable populations, such as children, elderly persons, or pregnant women. Combined interventions (e.g., co-application of drugs, electrophysiological measurements, neuroimaging) were not associated with further safety issues. Safety is established for low-intensity 'conventional' TES defined as <4mA, up to 60min duration per day. Animal studies and modeling evidence indicate that brain injury could occur at predicted current densities in the brain of 6.3-13A/m2 that are over an order of magnitude above those produced by tDCS in humans. Using AC stimulation fewer AEs were reported compared to DC. In specific paradigms with amplitudes of up to 10mA, frequencies in the kHz range appear to be safe. In this paper we provide structured interviews and recommend their use in future controlled studies, in particular when trying to extend the parameters applied. We also discuss recent regulatory issues, reporting practices and ethical issues. These recommendations achieved consensus in a meeting, which took place in Göttingen, Germany, on September 6-7, 2016 and were refined thereafter by email correspondence.

1 July 2006 in Clinical Neurophysiology
Verified
Journal Article
Closed access
PMPedro Cavaleiro Miranda
Pedro Cavaleiro Miranda
MLMikhail Lomarev
Mikhail Lomarev
MHMark Hallett
Mark Hallett

1 October 2012 in Brain Stimulation
Verified
Journal Article
Closed access
APAngel V. Peterchev
Angel V. Peterchev
TWTimothy A. Wagner
Timothy A. Wagner
PMPedro C. Miranda
Pedro C. Miranda
MNMichael A. Nitsche
Michael A. Nitsche
WPWalter Paulus
Walter Paulus
MBMarom Bikson
Marom Bikson

1 April 2014 in NeuroImage
Verified
Journal Article
Closed access
Giulio RuffiniGiulio Ruffini
Giulio Ruffini
MFMichael D. Fox
Michael D. Fox
OROscar Ripolles
Oscar Ripolles
PMPedro Cavaleiro Miranda
Pedro Cavaleiro Miranda
APAlvaro Pascual-Leone
Alvaro Pascual-Leone

1 April 2013 in NeuroImage
Verified
Journal Article
Closed access
PMPedro Cavaleiro Miranda
Pedro Cavaleiro Miranda
AMAbeye Mekonnen
Abeye Mekonnen
RSRicardo Salvador
Ricardo Salvador
Giulio RuffiniGiulio Ruffini
Giulio Ruffini